top of page

H7 Accelerator


 Empowering Healthcare Startups for Strategic Growth and Success

ABOUT H7 ACCELERATOR

H7 BioCapital offers a Once-a-Year virtual accelerator program specifically designed for healthcare companies from Seed to Series A stages. This 4-months long, equity free program features two specialized tracks: Life Science and Medtech, providing a unique opportunity to immerse in Silicon Valley and achieve strategic business objectives.​

With most of the portfolios either nearing the closure of their seed round funding, or preparing for their Series A round, this program focus primarily on fundraising and partnership opportunities. Throughout the program, companies will engage in weekly one-on-one meetings with investors mentors from our extensive network of 100+ advisors. They will also pitch both in-person and virtually during Demo Day and other conference organized by H7 and our network partners. 

​Additionally, the Life Science track emphasizes pre-clinical and clinical development plans and licensing-out opportunities, while the Medtech track concentrates on commercializing or expanding in the U.S. market. 

HIGHLIGHTS

Exceptional Quality

100+ Mentors

One-on-one mentor meetings

80+
VCs

Partnering with H7 Accelerator

Fund Raisings

Primary Focus of the Program

12+
Weeks

Virtual program

12+

Workshops

Customized to Cohorts

Free

Consultation

Tax, legal, FDA regulation, AWS credits

OUR ADVISOR NETWORK

One-on-one mentorship

Once you're selected for an accelerator cohort, you'll be part of the H7 community for life. Expand your business and expand your network with access to a talented group of founders, investors, mentors, and industry leaders.

Venture Capital
Clinical Trial
Marketing/Sales
CRO
Team Recruitment
Business Development
Manufacturing
FDA Regulations
Legal/Patent
Hospital Management
Clinician
Software Development
Finance
Science
Ella Li

Ella Li

Founding Partner

H7 BioCapital

Gary Goldman

Gary Goldman

Founding Partner

Global Health Impact Fund

Bill Reichert

Bill Reichert

General Partner

Pegasus Tech Ventures

Ted Hou

Ted Hou

Founding Partner

Berkeley Catalyst Fund

Stephan Pflanz

Stephan Pflanz

Executive Director

Boehringer-Ingelheim Venture Fund

Neil J. Littman

Neil J. Littman

Managing Director

Bioverge Ventures

logo.png

INDUSTRIAL FOCUS

Cutting-edge healthcare innovations

Life Science Track

Stage: Angel to Series A

We innovate within the biotech/biopharma sectors. Our focus areas include drug discovery, personalized medicine, synthetic biology, advanced drug delivery systems, and more. Join us in advancing these cutting-edge fields to revolutionize drug development and transform healthcare.

Medtech Track

Driving innovation in medical technology to enhance patient care and healthcare delivery. Our initiatives span across digital medicine, AI integration, cutting-edge medical devices

and digital health platforms aimed at enhancing clinical outcomes and optimizing healthcare processes.

Stage: Angel to Series A

2024 COHORT TIMELINE

Apply now

Applications Open

June 20th 

Early Bird Due

July 30th 

Applications Due

August 15th

Program Launch

September - December 2024

Demo Day Event

January 2025

Interview videos

PREVIOUS COHORT INTERVIEWS

Cutting-edge healthcare innovations

FAQS

FAQ

Subscribe to our news letter. Don't miss out!

Thanks for subscribing!

©2022 H7 BioCapital

All rights reserved.

bottom of page